(Q34062883)

30 July 2017

title

Conventional brain MRI in neuromyelitis optica (English)

1 reference

magnetic resonance imaging

30 July 2017

main subject

0 references

1 reference

I Kister

2

0 references

author name string

J A Cabrera-Gomez

series ordinal

1

1 reference

30 July 2017

publication date

31 October 2011

1 reference

European Journal of Neurology

30 July 2017

published in

1 reference

30 July 2017

volume

19

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

812-819

1 reference

Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

The molecular basis of water transport in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

EFNS guidelines on diagnosis and management of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Demyelinating disorder of the central nervous system occurring in black South Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Optic neuromyelitis syndrome in Brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Brain magnetic resonance imaging findings in relapsing neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Brain magnetic resonance imaging abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Neuromyelitis optica in Brazil: a study on clinical and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Characteristic linear lesions and longitudinally extensive spinal cord lesions in Chinese patients with neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Neuromyelitis optica in France: a multicenter study of 125 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

A population-based study of neuromyelitis optica in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Spectrum of pediatric neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

CNS aquaporin-4 autoimmunity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Long-term follow-up of neuromyelitis optica with a pediatric onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

NMO in pediatric patients: brain involvement and clinical expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

"Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Occurrence of acute large and edematous callosal lesions in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Absence of cortical demyelination in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Gray matter atrophy in multiple sclerosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Neuromyelitis optica and concentric rings of Baló in the brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

Preferential spinal central gray matter involvement in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03565.X

10.1111/J.1468-1331.2011.03565.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference